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Background: Insecticide-treated bed nets (ITN) reduce malaria morbidity and mortality consistently in Africa, but
their benefits have been less consistent in Asia. This study’s objective was to evaluate the malaria protective efficacy
of village-wide usage of ITN in Western Myanmar and estimate the cost-effectiveness of ITN compared with
extending early diagnosis and treatment services.
Methods: A cluster-randomized controlled trial was conducted in Rakhine State to assess the efficacy of ITNs in
preventing malaria and anaemia in children and their secondary effects on nutrition and development. The data
were aggregated for each village to obtain cluster-level infection rates. In total 8,175 children under 10 years of age
were followed up for 10 months, which included the main malaria transmission period. The incidence and
prevalence of Plasmodium falciparum and Plasmodium vivax infections, and the biting behaviour of Anopheles
mosquitoes in the area were studied concurrently. The trial data along with costs for current recommended
treatment practices were modelled to estimate the cost-effectiveness of ITNs compared with, or in addition to
extending the coverage of early diagnosis and treatment services.
Results: In aggregate, malaria infections, spleen rates, haemoglobin concentrations, and weight for height, did not
differ significantly during the study period between villages with and without ITNs, with a weighted mean
difference of −2.6 P. falciparum episodes per 1,000 weeks at risk (95% Confidence Interval −7 to 1.8). In areas with a
higher incidence of malaria there was some evidence ITN protective efficacy. The economic analysis indicated that,
despite the uncertainty and variability in their protective efficacy in the different study sites, ITN could still be
cost-effective, but not if they displaced funding for early diagnosis and effective treatment which is substantially
more cost-effective.
Conclusion: In Western Myanmar deployment of ITNs did not provide consistent protection against malaria in
children living in malaria endemic villages. Early diagnosis and effective treatment is a more cost effective malaria
control strategy than deployment of ITNs in this area where the main vector bites early in the evening, often before
people are protected by an ITN.
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Malaria is a major cause of morbidity and mortality in
Myanmar. Malaria control activities in this country have
been concentrated on early, mostly clinical, diagnosis
and treatment. Limited availability of curative services in
remote areas, the difficulties in accessing malarious areas,
and the relatively high costs of effective treatment of
multi-drug resistant malaria, have compromized malaria
control efforts. Effective malaria control activities are
needed, and there is a recent substantial increase in donor
support for these activities [1]. Levels of chloroquine and
sulphadoxine-pyrimethamine resistance in Plasmodium
falciparum have been high in this region for decades
[2,3]. Subsidies for highly effective artemisinin combin-
ation treatment (ACT) [4,5] have considerably increased
their availability in recent years. Unfortunately artemisinin
monotherapies are still widely available providing con-
tinued selective pressure on emerging artemisinin re-
sistance in the east of the country [6,7]. Regular and
systematic indoor spraying of residual insecticides was
stopped in 1993 and is now only used for special situations
(outbreaks, new settlements).
Largely ignored by the outside world until 2007, since
then there has been an over fifty-fold increase in exter-
nal donor funding for malaria control in Myanmar, the
majority of which has been spent on insecticide-treated
mosquito nets (ITN). ITNs are an appealing approach to
the control of malaria. They repel and kill malaria vectors,
and they prevent sporozoite-bearing anopheline mosqui-
toes from biting the occupants lying under or near the
bed net. ITNs have been shown to exert a mass effect re-
ducing vector populations in villages with extensive use
and high transmission [8]. ITNs are usually greatly appre-
ciated by their occupants, because they prevent all kinds
of insect bites, and they are very safe. Overall use of
ITNs prevented approximately one in five childhood
deaths in sub-Saharan Africa [9]. These substantial benefits
have rightly led to the inclusion of ITNs as a central com-
ponent of many malaria control initiatives throughout the
world. In endemic areas of South and South-East Asia,
where malaria transmission is lower and unstable, mobile
young adult males are particularly affected, and vector
behaviour is different, the results of ITN efficacy stud-
ies are mixed, and much less clear than in Africa
[10-14]. This is not because of insecticide resistance,
although some vector species do exhibit low-grade pyr-
ethroid resistance [15], but because of the behaviour of
the vectors which often bite early in the evening or morn-
ing outdoors or away from dwellings, and the correspond-
ing behaviour of humans. ITN always provide some
protection against malaria – the critical question is how
much? All individuals in malaria endemic areas should
ideally have ITN, even if they provide only modest benefit,
but whilst there are financial constraints, choices need tobe made. It is necessary therefore to assess the efficacy of
ITN in the South and South-East Asian region at a local
level to assist decisions on their wider-scale deployment in
relation to alternative proven highly effective malaria con-
trol measures (i.e. early diagnosis and effective treatment:
EDAET). The effectiveness of ITN in reducing malaria
morbidity and mortality depends on several factors, includ-
ing the level of malaria endemicity and the behaviour and
immunity of the population, the climate, the acceptance
and usage of the ITN by the population and, crucially, the
biting behaviour of the main anopheline vectors [16].
A cluster-randomized controlled trial was carried out
in Western Myanmar, to evaluate the protective efficacy
of village-wide usage of insecticide-impregnated ITNs
on malaria incidence and prevalence, anaemia, and the de-
velopment of children. The anopheline vector abundance
and biting behaviour were also studied, and data were col-
lected on population sleeping habits, to assess the potential
of ITNs to reduce man-mosquito contact in this region;
these findings are described in the accompanying paper.
While effective diagnosis and treatment facilities were
an ethical and research necessity in the study setting,
these are often not present in routine settings. Budgetary
limitations may result in ITN programmes competing with
EDAET services for limited resources. A cost-effectiveness
analysis was therefore carried out to assess the costs and
benefits of ITN when compared with those of EDAET
when neither has been implemented, and to assess the
incremental cost-effectiveness of introducing one of the
interventions when the other is already in place.
Methods
Study area and population
The study was conducted in Rakhine State, Western
Myanmar. The monsoon season is from May to October
and yearly rainfall is very high (+/− 5000 mm/year). Malaria
transmission occurs throughout the year and peaks during
the post monsoon (November-January), and sometimes
in the early monsoon (June-July) periods (Figure 1). The
transmission intensity varies from predominantly low to
pockets of intense transmission, depending on the location,
and there are considerable variations over short geographic
distances and also between years and between seasons.
Symptomatic malaria occurs at all ages but is seen pre-
dominantly in children. Access to effective treatment
has historically been very poor. Outbreaks of falciparum
malaria can spread over several townships, or may be
limited to a single village at other times.
In 1994, Médécins Sans Frontières - Holland (MSF-H)
began a malaria control programme in Rakhine State in
cooperation with the Myanmar VBDC (Vector Borne
Disease Control) department [2]. The programme focussed
on early diagnosis and treatment, through support of 30















































































































































Figure 1 Climate and seasonal malaria incidence in Rakhine State in 1998–1999. Upper. Monthly rainfall and minimum/maximum
temperature, average of Sittwe and Maungdaw Townships (data obtained from township weather stations). Lower. Monthly number of
malaria-patients visiting 6 malaria clinics in the region (not only at the study sites).
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for approximately 80% of the malaria infections in pa-
tients who presented to these clinics. Drug resistance in
P. falciparum in the area was studied in 1995; high levels
of resistance were found with treatment failure rates of 82%
to chloroquine and 67% to sulphadoxine-pyrimethamine,
whereas mefloquine was very effective (93% cure rate) [2].
Since 1996 all patients with falciparum malaria have been
treated with a combination of mefloquine and artesunate
[3-5]. Between 1997 and 2007 over one million patients
(approximately 43% of whom were children under 10 years
of age) received treatment for slide confirmed malaria,
supported by this programme. It was unclear whether
ITN should be deployed as a priority so the effectiveness
of ITN was studied between May 1998 and February 1999,
covering the peak malaria transmission season, in villages
around two Rural Health Clinics (RHC), in Dabhine and
Myothugyi, two village-tracts located in the townships
Sittwe and Maungdaw, which are approximately 90 km
apart. The study villages in the Dabhine area are all
within 5 miles from the Bay of Bengal. This is a coastalplain area without hills or forest, where rice and other
crops are cultivated. Common breeding sites for Anophelines
are paddy fields, brackish water in streams and tide
pools and saline ponds used for prawn culture which
are close to villages, swamps, and small ponds used for
growing watercress. The area was classified generally as
meso- to hyperendemic for malaria. A malaria blood-slide
survey, performed in September 1995, found a prevalence of
34% for P. falciparum and 11% for Plasmodium vivax, and a
spleen prevalence of 36% among primary school children.
Myothugyi is a densely populated area situated 5–7
miles from the Bay of Bengal. The area is characterized
by rice-fields and partly forested hills. Potential breeding
sites for Anophelines are freshwater creeks, ponds and
stagnant water in rice fields, as well as brackish water in
tide pools, prawn-breeding ponds and small pools and
streams at foothills. It has been classified generally as a
low meso-endemic malaria area. A malaria blood-slide
survey in January 1996, 10 kilometres south of Myothugyi,
found a prevalence of 13% for P. falciparum and 3% for
P. vivax and none of the primary schoolchildren examined
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tial burden of malaria in children, prompted discussions
with the community and authorities as to what control
measures could be applied. In view of the uncertainties over
ITN efficacy and their limited availability at the time, and
after consultation with the authorities and village leaders, it
was decided jointly that an evaluation was needed to set
priorities before consideration of wide-scale deployment. It
was agreed that if there was any evidence of benefit,
then after the evaluation, ITNs would be given to all
villages included in the evaluation.
Study design, randomization and sample size calculation
Ideally, a study population is randomized on an individual
or household basis. However, the use of insecticide-
impregnated bed nets (ITN) has an impact on the vector
populations in the nearby environment and, therefore, on
malaria transmission and risk, not only in the household
itself, but also among people living nearby, including those
who do not have ITN (the “mass” effect). Therefore, the
unit chosen for randomization in this study was the village
[17], and this was agreed with the village leaders in consult-
ation with the community. The primary outcome measure
was the incidence and prevalence of malaria in children.
In December 1997 and January 1998 a population survey
was done in the study areas. Outreach Workers (ORW)
were trained to register all families, number houses, and to
collect demographic data on family size and number of
children under 10 years of age. During this period, a sample
of the population of children under 10 was checked for
parasitaemia and splenomegaly. The results of the pre-
intervention survey were used to determine the number
of clusters and the sample sizes needed for the larger study.
The pre-intervention malaria survey was performed
on 1,088 children (Table 1). The intra-class correlation
coefficient (ICC) calculated on the basis of the pre-
intervention data was 0.048, with a between-cluster
variation of 0.006 and within-cluster variation of 0.12
[18]. The prevalence of P. falciparum parasitaemia by
microscopy averaged 17% (range 0 – 53%). Microscopy
was quality assured throughout the study with independ-
ent cross-checking. The number of village-clusters and
their size needed for a valid comparative study was calcu-
lated using the methods described by Thompson [19]. In
order to detect a 50% reduction in the incidence of falcip-
arum malaria, with 80% power at a 5% significance level, a
total of 10 village pairs were required with an average of
420 children per village, amounting to a total sample size
of 8,400 children.
Initially, 22 villages were informed about the study-
procedures and were invited to participate, but after further
discussions two villages declined to join. Finally 20 villages
(clusters) were paired, and for each pair one was selected
randomly (using a computer generated random number) toreceive impregnated bed nets (ITNs), while the other acted
as the control village. Matching was done according to
geographical location so that the intervention and con-
trol villages were nearby (villages were 1–2 miles apart).
This minimized differences in the environment in and
around each village pair (i.e. proximity to foothills, forest
fringe, prawn-ponds, rice-fields, waterways), which could
have had a strong influence on vector populations and
consequently on the prevalence and incidence of malaria.
The travel-time to the health clinic and its influence on
the number of patient visits, and therefore on malaria
incidence, were comparable for intervention and con-
trol villages, as the distances were matched equally.
ITN distribution
Between the 26th and 29th of April 1998, all households
in the intervention villages received a number of ITNs,
according to the number of family members and were
instructed explicitly about the correct use of the nets
(Figure 2). More than 5000 ITN were distributed. The
ITN (green colour, polyester, size 130 × 180 × 150 cm
(11.6 m2) or 190 × 180 × 150 cm (14.5 m2), Siam-Dutch
Co, Thailand) were already impregnated with deltamethrin
(25 mg/m2) by the manufacturer. All households of the
control villages received ITNs after the study was com-
pleted in May 1999.
Incidence surveillance
Malaria morbidity surveillance consisted of passive case
detection. Each family from both study groups received a
specific registration card at the beginning of the study and
anyone with complaints of fever was urged to visit the RHC
and bring the registration card. In both study areas a RHC
operated by staff from the Department of Health, was
supported by doctors, microscopists, and out-reach workers
from MSF-H. Microscopy was quality checked on a regular
basis. The RHCs were open seven days a week. Out-reach
workers regularly visited the villages and informed the popu-
lation about using the clinics in case of illness. In the RHC
blood-smears of patients with fever or a history of fever
were examined for malaria parasites. Data-files were kept for
all children under 10 years coming from the villages under
study. Patients with falciparum malaria were treated with a
single dose of mefloquine 15 mg base/kg and artesunate
4 mg/kg (then the current treatment) [4]. Vivax malaria was
treated with chloroquine (10 mg base/kg on day 0 and 1,
5 mg/kg on day 2), followed by primaquine (0.25 mg base/
kg/day for 14 days). Patients who were not part of the study
were also provided with medical services. No other signifi-
cant health services were available in the areas under study.
Cross-sectional surveys
After distribution of ITN, children were followed up for
weight, height and haemoglobin at three time-points: at the
Table 1 Plasmodium falciparum, Plasmodium vivax and splenomegaly prevalences in ITN and control villages during
the pre-study malaria survey (December 1997)
Intervention villages Control villages
N M.S. Pf (%) Pv (%) Spleen (%) N M.S. Pf (%) Pv (%) Spleen (%)
Dabhine
Pair 1 707 125 37 (30) 35 (28) 79 (63) 796 102 38 (37) 33 (32) 68 (67)
Pair 2 551 89 26 (29) 33 (37) 47 (53) 679 48 9 (19) 7 (15) 16 (34)
Pair 3 462 37 8 (22) 10 (27) 16 (42) 298 49 11 (22) 6 (12) 30 (61)
Pair 4 223 33 7 (21) 8 (24) 9 (28) 184 32 4 (13) 16 (50) 19 (59)
Pair 5 74 18 3 (17) 4 (22) 5 (28) 87 15 8 (53) 1 (7) 6 (40)
Subtotal 2017 302 81 (27) 90 (30) 156 (52) 2044 246 70 (28) 63 (26) 139 (57)
Myothugyi
Pair 6 78 16 3 (19) 1 (6) 6 (38) 47 15 3 (20) 0 (0) 1 (7)
Pair 7 714 96 1 (1) 0 (0) 15 (16) 819 105 0 (0) 0 (0) 30 (29)
Pair 8 492 54 0 (0) 1 (2) 13 (24) 602 70 2 (3) 1 (1) 6 (9)
Pair 9 659 57 4 (7) 4 (7) 7 (12) 650 82 1 (1) 0 (0) 1 (1)
Pair 10 153 25 10 (40) 2 (8) 8 (32) 120 20 7 (35) 1 (5) 4 (20)
Subtotal 2096 248 18 (7) 8 (3) 49 (19) 2238 292 13 (4) 2 (1) 42(14)
Total 4113 550 99 (18) 98 (18) 205 (37) 4282 538 83 (15) 65 (12) 181 (34)
N = number of children < 10 yrs (data from local authorities).
MS = number of children of whom a malaria smear was taken.
Pf = P. falciparum prevalence (including mixed infections), Pv = P. vivax prevalence (including mixed infections).
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5 months (14 Sept- 9 Oct. 1998) and at the end of the study
(25 Jan - 22 Feb 1999) (Figure 2). During the last survey a
blood-smear for the detection of malarial parasitaemia was
taken as well. During the surveys people were asked about
the usage of ITN and whether they had washed their ITN.Figure 2 Time frame of the study of insecticide treated mosquito net
study areas.Ethics statement
The study was discussed in detail with community rep-
resentatives of each village and with officials from the
Ministry of Health. There was general agreement on the
need for an evaluation but no local ethical review com-
mittee or relevant formal organizational ethics reviews and entomological surveys [17] between 1995 and 2000 in the
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reasons for the study were discussed and it was explained
that individual or community decision to participate or not
would not in any way jeopardize anti-malarial screening,
treatment, or subsequent deployment of ITN. Villages were
included in the study only after extensive discussions and
full approval of the village representatives. Many study
participants were illiterate, and for these individuals fully
informed witnessed verbal consent was obtained from
adults and the parents of children involved in the study.
The Myanmar National Health authorities granted ap-
proval for this study.
Statistical analysis
Malariometric data
This study was designed as a cluster randomized trial
and, therefore, the data were aggregated for each village
(i.e. cluster) to obtain cluster-level infection rates. This
approach is appealing because the cluster is both the
unit of randomization and the unit of analysis. The vil-
lages with bed nets were then compared to the other vil-
lages using a weighted paired t test [19,20]. The results
of blood smears, collected at the clinics, were used to
calculate the incidence density of P. falciparum, defined
as the number of malaria episodes per 1,000 child-weeks
at risk. The number of weeks at risk for each child was
calculated from the start of the study till the end of the
study (the last malaria prevalence survey) or the final
date they were seen before they moved or died. If chil-
dren moved in the first half of the study (before the 2nd
prevalence survey), the weeks at risk could be not calcu-
lated and these children were, therefore, excluded from
the analysis of malaria episodes per 1,000 child weeks at
risk. If children moved in the second half of the study,
the weeks at risk were taken from the first half of the
study. Children who had falciparum malaria were treated
with mefloquine and artesunate and were considered not at
risk of reinfection because of post-treatment prophylaxis
for four weeks following treatment. Three categorical vari-
ables were also calculated, in which each child was classified
to have one or more infections with either P. falciparum,
P. vivax or “all species of malaria (i.e. any malaria)” between
11 May 1998 and 27 February 1999. This was analysed on
an intention-to-treat basis. Data from the cross-sectional
surveys were also aggregated to obtain cluster-level preva-
lences of malaria, anaemia, and malnutrition.
Cost-effectiveness analysis
Four scenarios were modelled for the costs and benefits
of malaria control using ITN and/or EDAET as compared
with a baseline of no intervention. The study data on inci-
dence of P. falciparum cases in the individual villages were
used, with Poisson distributions assigned to each of these
independently, to capture the uncertainty and variability inthese findings. Incidence data for vivax cases per village
were not available and the proportion of children with
at least one case of vivax over the study period was,
therefore, adapted as a proxy for incidence (likely to be
an under-estimate of actual incidence), and converted to
the rate per 1,000 person weeks. The costs of diagnosis,
treatment and ITN were adapted to present day (2013)
recommended strategies and their current costs (i.e. rapid
tests for the diagnosis of malaria prior to treatment, the
current recommended dosage of artemether-lumefantrine
for falciparum malaria, continued use of chloroquine with
primaquine for vivax malaria, and the use of long-lasting
insecticide treated nets (LLIN) instead of ITN). A cost for
village malaria workers was also included, that would be re-
quired for the EDAET strategy at $1.05 per child per annum
(adapted from a study of VMWs in Cambodia [21]).
The costs of treatment are based on the currently
recommended dose regimen of 3 days of artemether-
lumefantrine (current first line policy); the provider
unit costs in Myanmar in 2013 for a full treatment course
for children weighing between 5-14 kg was $0.47 and for
children weighing 15-24 kg it was $0.94. The cost of one
chloroquine tablet was $0.021 and for primaquine it was
$0.015. The cost of RDTs was estimated at $0.8. An extra
15% was added to the costs of diagnostics and treatment
for shipping and wastage. The cost of LLIN including
delivery was assumed to be $10 based on a recent re-
view of LLIN costs which conformed with estimates
from donors currently active in Myanmar [18]. It was
assumed that each ITN is shared by 1.8 people on average
(while ITN can be shared by two children a family of five
will receive three nets) and that they have a useful life of
three years.
These costs were applied for each 1,000 person-weeks.
Clinical cases of falciparum malaria were converted to
disability-adjusted life-years (DALYs) assuming a mor-
tality rate of 0.1% in treated cases and 1% in untreated
P falciparum cases, and a mortality rate of 0.01% and 0.05%
in vivax malaria respectively. Modelling also assumed a
one-week total duration of illness for uncomplicated treated
malaria and four weeks for untreated malaria. Results were
generated by running 10,000 Monte Carlo simulations sam-
pling from the probability distributions and calculating the
mean costs and effects for each strategy. Cost-effectiveness
acceptability curves were generated to summarize the
parameter uncertainties and identify which strategy was
most likely to be cost-effective across a range of willingness
to pay thresholds.
Results
Characteristics of study groups
During December 1997 and January 1998 data were
collected from 1,088 children (13.3% of the total study
population) on the prevalence of malaria and palpable
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portions of children with P. falciparum and/or P. vivax
parasitaemia, and palpable spleens among the clusters
(Table 1). In May 1998, immediately after the ITN were
distributed (but before ITN could have had an impact
on malaria related pathology), base-line demographic
and clinical data of the study children were gathered. A
total of 8,175 children were recruited from twenty
clusters. The age and sex distributions of children were
similar for the intervention (4,066 children) and control
villages (4,109 children), as were the variables “weight for
height”, and the proportions of children with anaemia
(Hgb < 10.0 g/dL).
Incidence of malaria
During the study-period (10 May 1998 to 28 February
1999) [42 weeks], 2,408 children visited the clinics with
complaints of fever and were confirmed by microscopy
to have malaria; 1,102 P. falciparum (46%), 1,257 P. vivax
(52%), and 49 mixed i.e. with both species (2%). Of the
children infected with P. falciparum who visited the
clinics, 15.5% came twice with a P. falciparum infection
(32 from ITN clusters and 117 children from NN clusters),
1.8% came three times (two from ITN cluster and 15 from
NN clusters), and three children (NN cluster) came four
times with a P. falciparum infection during the 10-month
follow up period. The number of P. falciparum episodes
per 1,000 child-weeks at risk was calculated for each cluster
(Table 2, Figure 3). There was considerable heterogeneity in
the effects. Eight out of the ten ITN villages showed some
protective efficacy against falciparum malaria compared to
their control village while the remaining two village pairs
showed the opposite trend. The study design (by cluster)Table 2 Falciparum malaria incidence per 1,000 weeks exposu
February 1999)
ITN villages
N Pf episodes per 1,000 weeks exposure N Pf e
Dabhine
Pair 1 677 4.04 (97 /24034) 715
Pair 2 522 7.37 (137 /18592) 653
Pair 3 429 1.57 (24 /15304) 280
Pair 4 208 2.83 (21 /7411) 171
Pair 5 67 2.13 (5 /2343) 71
Myothugyi
Pair 6 74 3.68 (9 /2447) 44
Pair 7 737 0.23 (6 /26632) 786
Pair 8 482 0.06 (1 /17344) 595
Pair 9 653 1.61 (37 /22973) 631
Pair 10 140 2.90 (14 /4824) 107
Total 3,989 2.47 (351 /141903) 4053provides a limited number of data points so further inves-
tigation by stratifying clusters by transmission and other
characteristics was not feasible. The protective effect of
ITN appeared to increase in both relative and absolute
terms with the incidence of malaria in the control village
in each cluster pair (Figure 3). However the weighted dif-
ference between the intervention and control villages for
the incidence density of P. falciparum was not statistically
significant (weighted mean difference of −2.6 episodes per
1,000 weeks at risk, (95% Confidence Interval; -7 to 1.8);
p = 0.22).
Twelve children (1% of acute falciparum malaria)
developed severe falciparum malaria; in Dabhine, six
severe patients were reported from the NN-villages and
two from the ITN-villages. In Myothugyi, one severe pa-
tient was reported from the NN-villages and three from the
ITN-villages. Thus, overall seven children developed severe
malaria in NN villages and five in ITN villages.
Seven out of 10 village pairs showed a protective effi-
cacy of ITN for both one or more falciparum malaria
episodes and one or more vivax malaria episodes while
the remaining three village pairs showed the opposite
trend. The overall proportion of children having had
one or more malaria episode was 16.3% in ITN villages
and 22.5% in NN villages, a weighted difference of −6.4%
(95% CI; -21.2% to 8.4%), p = 0.35 (Table 3, Figure 4).
For P. falciparum this was 8.4% (341/4066) in ITN villages
and 15.2% (618 /4109) in NN control villages respectively,
a weighted difference of −6.9% (95% CI; –18.9% to 5.1%),
p = 0.23, and for P. vivax, 9.9% (401/4066) in ITN vil-
lages versus 12.3% (505/4109) in NN villages, a weighted
difference of −2.6% (95% CI; -10.9% to 5.7%), p = 0.25
(Table 3).re in ITN and control villages (from 10 May 1998 to 28
Control villages ITN Protective efficacy
pisodes per 1,000 weeks exposure Rate ratio Rate difference
15.25 (376 /24662) 0.26 −11.21
3.51 (83 /23625) 2.09 +3.86
9.38 (91 /9697) 0.17 −7.81
8.03 (48 /5980) 0.35 −5.20
13.32 (33 /2477) 0.16 −11.19
3.84 (6 /1562) 0.96 −0.16
0.46 (13 /28427) 0.50 −0.23
0.97 (21 /21637) 0.06 −0.91
0.57 (13 /22852) 2.82 +1.04
7.68 (29 /3775) 0.38 −4.78
4.93 (713 /144694) weighted paired t-test p = 0.216
Figure 3 Incidence rate ratio of P.falciparum for ITN versus control (NN) villages by incidence rate (per 1000 weeks) in the
control villages.
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There was no significant trend for falciparum malaria-
infection by age. Restricting the analysis to children under
five years of age, similar results were observed compared to
the whole study group. Vivax malaria was more common
among younger children. Relapse of vivax malaria cannot
usually be distinguished reliably from incident infection,
although first infections of life are by definition incident.
Among children under one year of age, 143 (17,5%) had at
least one vivax infection during the 10 month study period
(13.7% in ITN villages and 21.0% in NN villages) and chil-
dren in their second year of age had 185 (19.4%) infections
(18.1% in ITN villages and 20.7% in NN villages). After
the second year the proportion of children with an epi-
sode of vivax malaria decreased steadily by age and only
3.7% of 9-year-old children (3.8% in ITN villages and
3.7% in NN villages) had an episode of vivax malaria in
the same period.
Cross-sectional surveys
Of the 8175 children registered, 7764 (95%) were present
at all three ‘prevalence’ surveys. Of the other 411 chil-
dren, 46 children reportedly died during the study-
period (overall child mortality 5.62% in the 42 weeks),
(20 from NN villages and 26 from ITN villages; p > 0.2) and
365 had moved out of the area or were absent during one
or two of the follow-up surveys (NN 142, ITN 223).
Malaria prevalence
The prevalences of children with malaria and splenomegaly
were measured at the end of the study (January – early
February 1999), which coincided with the end of the
peak transmission season. A total of 7,828 children werepresent at this survey. There was considerable variation in
malaria prevalence, both for P. falciparum and P. vivax,
and also in the splenomegaly prevalences among the vil-
lages (Table 4, and in further detail in Additional files 1, 2,
3 and 4). The overall prevalence of P. falciparum was 5.7%
(225) in NN villages and 4.2% (161) in ITN villages. Some
protective efficacy from impregnated bed nets was seen in
six village pairs, while four village pairs showed the oppos-
ite effect; overall difference - 1.9% (95% CI; -5.8% to 2.0%),
p = 0.30 (Additional files 5, 6 and 7). For P. vivax the overall
prevalence was 14.2% (564) in NN and 11.6% (446) in ITN
villages. Four village pairs suggested protection by ITN
while five did not, and in one village pair, both clusters,
had no vivax malaria at all; overall difference = −2.8%
(95% CI; - 8.5%, 2.9%); p = 0.30. For splenomegaly preva-
lence, six village pairs suggested protection by ITN, while
four did not; overall difference = − 7.3% (95% CI; - 20.1%,
5.5%), p = 0.23. The overall splenomegaly prevalence was
14% in bed net villages and 21% in non-bed net villages.
Anaemia and malnutrition
The prevalences of anaemia (Hb <10 g/dL) and malnutrition
(Wt/Ht; Z-score < −2) at baseline in the ITN and NN
villages were similar. The weighted mean difference in the
prevalence of anaemia was −5.2% (ITN-NN; 95% CI: -13.8%,
3.4%) and the weighted mean difference in the prevalence
of malnutrition was 0% (ITN-NN; 95% CI: -4%, +4%). The
mean haemoglobin level of children during the first cross-
sectional survey was lower in Myothugyi (8.85 g/dL; village
means varying from 7.84 to 9.24 g/dL) than in Dabhine
(9.70 g/dL; village means varying from 9.15 to 10.02 g/dL).
The proportion of anaemic children (Hb < 10 g/dL) de-
creased during the study period in all but two clusters
Table 3 Proportion of children (%) with one or more malaria infections during the study
P. falciparum- ever P. vivax - ever Any malaria – ever













Pair 1 695 740 89 305 0.31 - 28.4 151 243 0.66 - 11.2 214 429 0.53 - 27.2
(12.8) (41.2) (21.7) (32.9) (30.8) (58.0)
Pair 2 527 662 126 80 1.98 + 11.8 120 72 2.09 + 11.9 215 139 1.94 + 19.8
(23.9) (12.1) (22.8) (10.9) (40.8) (21.0)
Pair 3 441 285 26 81 0.21 - 22.5 46 64 0.43 - 13.8 67 120 0.36 - 26.9
(5.9) (28.4) (10.4) (22.5) (15.2) (42.1)
Pair 4 213 176 24 46 0.43 - 14.8 32 60 0.44 - 19.1 53 89 0.49 - 25.7
(11.3) (26.1) (15.0) (34.1) (24.9) (50.6)
Pair 5 67 72 5 29 0.19 - 32.8 6 33 0.20 - 36.8 11 49 0.24 - 51.7
(7.5) (40.3) (9.0) (45.8) (16.4) (68.1)
Myothugyi
Pair 6 77 44 8 4 1.14 + 1.3 6 0 3.35 + 5.4 12 4 1.71 + 6.5
(10.4) (9.1) (7.7) (0) (15.6) (9.1)
Pair 7 745 792 6 13 0.05 - 0.8 1 4 0.20 - 0.4 7 16 0.45 - 1.1
(0.8) (1.6) (0.1) (0.5) (0.9) (2.0)
Pair 8 489 598 1 23 0.05 - 3.6 6 13 0.56 - 1.0 7 34 0.25 - 4.3
(0.2) (3.8) (1.2) (2.2) (1.4) (5.7)
Pair 9 664 632 38 13 2.71 + 3.6 28 6 4.20 + 3.2 59 17 3.30 + 6.2
(5.7) (2.1) (4.2) (1.0) (8.9) (2.7)
Pair 10 148 108 18 24 0.55 - 10.0 5 4 0.92 - 0.3 19 26 0.53 - 11.3
(12.2) (22.2) (3.4) (3.7) (12.8) (24.1)
Total 4066 4109 341 618 401 505 664 923
(8.4) (15.0) (9.9) (12.3) (16.3) (22.5)
Weighted
paired t-test
p = 0.23 p = 0.25 p = 0.35
P. falciparum-ever includes P. falciparum +mixed, P. vivax-ever includes P. vivax +mixed. ITN: insecticide treated nets, NN: no nets.
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survey, the decrease in the proportion of children with
anaemia in bed net villages was more pronounced than
in control villages in 7 cluster pairs while 3 pairs
showed the opposite trend (Table 5). The prevalences
of anaemia at the end of the study were not signifi-
cantly different comparing NN and ITN clusters
(weighted mean difference of - 3.3% (95% CI; - 11.3,
4.7), p = 0.38 (Additional file 8).
The proportion of children with moderate acute mal-
nutrition (Wt/Ht; Z-score < −2) decreased over the study
period in 14 of the 20 villages; 8 ITN villages and 6 NN
villages (Table 5). At the final nutrition survey the de-
crease of malnutrition in ITN villages was greater than
in control villages in seven cluster pairs, while three
pairs showed a greater decrease in control villages. The
malnutrition prevalences at the end of the study were
not significantly different comparing NN and ITNclusters, either for all children under 10 years (− 1.7%
(95% CI; - 3.8, 0.4), p = 0.094), or for the children under
five years of age (− 1.8% (95% CI; - 5.9, 2.3), p = 0.35)
(Additional file 9).
Cost-effectiveness analysis of ITN and EDAET
The average weight of a child under 10 years of age pre-
senting to the malaria programme in Rakhine State was
12.7 kg, which puts the current cost of the drugs for the
treatment of falciparum malaria for an average person in
this study area at $0.62 and for vivax malaria at approxi-
mately $0.3. The model output suggests that in the ab-
sence of ITN or EDAET, 1.4 DALYs are accumulated per
1,000 person-weeks at no cost to the provider. The use
of ITN would add a cost of $35 and reduce the number
of DALYs to 0.69, or an incremental cost-effectiveness ra-
tio (ICER) of $51/DALY averted. The use of EDAET alone
would cost $23 per 1000 person-weeks and reduce DALYs
Figure 4 Risk difference in malaria (ever) in ITN villages by proportion compared with malaria in control (NN) villages.
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three times less). While both options are considered cost-
effective, the implementation of ITN instead of EDAET
would incur higher costs and avert less than a third of the
number of DALYs. Where EDAET is already in place the
introduction of ITN would avert an additional 0.2 DALYs
at a cost of $148 per DALY averted. The cost-effectiveness
acceptability curves (Figure 5) illustrate these results,
and show that if policy makers are willing to pay overTable 4 Plasmodium falciparum, Plasmodium vivax and spleno
during the peak season at the end of the study (January 199
N N P. falciparum
ITN NN ITN NN Prevalence
difference
Dabhine
Pair 1 659 708 31 (5) 107 (15) - 10.4
Pair 2 508 644 39 (8) 35 (5) + 2.3
Pair 3 413 268 17 (4) 21 (8) - 3.7
Pair 4 203 169 10 (5) 6 (4) + 1.4
Pair 5 62 71 3 (5) 7 (10) - 5.0
Myothugyi
Pair 6 65 43 14 (22) 3 (7) + 14.6
Pair 7 717 763 2 (0) 5 (1) - 0.4
Pair 8 462 580 0 (0) 6 (1) - 1.0
Pair 9 627 620 5 (1) 3 (0) + 0.3
Pair 10 143 103 40 (28) 32 (31) - 3.1
Total 3859 3969 161 (4) 225 (6)
Weighted Paired t-test Pf : -1.9% (−5.8%, 2.0%),
p-value = 0.30
P. falciparum% and P. vivax% indicate the percentage of children with P. falciparum
treated nets, NN: no nets.approximately $280 per DALY averted, the combination
of both ITN and EDAET is likely to be cost-effective. If
resources are more constrained then EDAET alone will
always dominate the use of ITN alone.
This analysis derives from the data in this study and,
therefore, specifically to children in this area of Western
Myanmar. EDAET is likely to be equally effective in adults,
but ITNs are likely to be less effective in the adult popula-







183 (28) 280 (40) - 11.8 170 (26) 432 (61) - 35.2
120 (24) 135 (21) + 2.7 155 (31) 131 (20) + 10.2
57 (14) 83 (31) - 17.2 63 (15) 90 (34) - 18.3
23 (11) 25 (15) - 3.5 56 (28) 74 (44) - 16.2
23 (37) 22 (31) + 7.1 23 (38) 31 (44) - 5.9
7 (11) 1 (2) + 8.4 11 (17) 4 (9) + 7.6
0 (0) 0 (0) 0 6 (1) 23 (3) - 2.2
1 (0) 4 (1) - 0.7 1 (0) 9 (2) - 1.3
9 (1) 2 (0) + 1.1 11 (2) 3 (0) + 1.3
23 (16) 12 (12) + 4.4 37 (26) 23 (22) + 3.5
446 (12) 564 (14) 533 (14) 818 (21)
Pv : -2.8% (−8.5%, 2.9%), Spleen : -7.3% (−20.1%, 5.5%),
p-value = 0.30 p-value = 0.23
or P. vivax parasitaemia, both values include mixed infections. ITN: insecticide
Table 5 Prevalence of anaemia and malnutrition during the 1st and 3rd cross-sectional surveys
Malnutrition (Wt/Ht < −2Z1)
ITN clusters NN clusters
1st prevalence 3rd prevalence Change 1st prevalence 3rd prevalence Change Relative change
Pair 1 87/692 (13) 67/651 (10) −2.3% 98/728 (13) 76/701 (11) −2.6% −0.3%
Pair 2 61/516 (12) 58/506 (11) −0.4% 86/651 (13) 102/634 (16) +2.9% 3.3%
Pair 3 72/435 (17) 71/413 (17) +0.6% 51/277 (18) 43/266 (16) −2.5% −3.1%
Pair 4 62/210 (30) 28/201 (14) −15.6% 38/169 (22) 32/167 (19) −3.3% 12.3%
Pair 5 17/64 (27) 6/61 (10) −16.7% 11/71 (15) 6/70 (9) −6.9% 9.8%
Pair 6 8/77 (10) 2/65 (3) −7.3% 3/42 (7) 5/42 (12) +4.8% 12.1%
Pair 7 105/735 (14) 92/701 (13) −1.2% 158/780 (20) 92/760 (12) −8.2% −7.0%
Pair 8 60/486 (12) 56/450 (12) +0.01% 67/585 (11) 81/572 (14) +2.7% 2.7%
Pair 9 87/652 (13) 55/620 (9) −4.5% 64/627 (10) 78/612 (13) +2.5% 7.0%
Pair 10 39/148 (26) 8/140 (6) −20.6% 10/104 (10) 7/100 (7) −2.6% 18.0%
Total 598/4015 (15) 443/3808 (12) 586/4034 (15) 586/4034 (15) 522/3924 (13) −1.2% 2.1%
Anaemia (Hb <10 g/dL)
ITN clusters NN clusters
1st prevalence 3rd prevalence Change 1st prevalence 3rd prevalence Change Relative change
Pair 1 362/695 (52) 299/659 (45) −6.7% 440/739 (60) 413/708 (58) −1.2% 5.5%
Pair 2 303/527 (57) 235/508 (46) −11.2% 332/662 (50) 305/644 (47) −2.8% 8.4%
Pair 3 228/441 (52) 182/413 (44) −7.6% 152/285 (53) 125/268 (47) −6.7% 0.9%
Pair 4 133/213 (62) 88/203 (43) −19.1% 110/176 (63) 59/169 (35) −27.6% - 8.5%
Pair 5 46/67 (69) 22/62 (35) −33.2% 29/72 (40) 33/71 (46) +6.2% 39.4%
Pair 6 76/77 (99) 52/65 (80) −18.7% 42/44 (95) 40/43 (93) −2.4% 16.3%
Pair 7 485/745 (65) 602/716 (84) +19.0% 657/792 (83) 558/761 (73) −9.6% −28.6%
Pair 8 355/489 (73) 307/461 (67) −6.0% 532/597 (89) 473/579 (82) −7.4% −1.4%
Pair 9 579/664 (87) 443/627 (71) −16.5% 540/632 (85) 446/619 (72) −13.4% 3.1%
Pair 10 142/148 (96) 108/143 (76) −20.4% 104/108 (96) 95/103 (92) −4.1% 16.3%
Total 2709/4066 (67) 2338/3857 (61) −6.0% 2938/4107 (72) 2547/3965 (64) −7.3% −1.3%
1 Weighted paired t test 3rd prevalence Wt/Ht - 2 Z score, p-value = 0.094. Relative change = (Prev 3 - Prev 1) NN cluster - (Prev 3 - Prev 1) ITN cluster.
ITN: insecticide treated nets, NN: no nets.
Figure 5 Cost-effectiveness acceptability curves for the four
options, accounting for the uncertainty due to the variability
in the different study sites and varying levels of willingness
to pay per DALY averted.
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dren. Thus the comparative economic advantage of EDAET
over ITN is likely to be even greater in adults and, therefore,
the overall advantage of EDAET over ITN for the popula-
tion overall is predicted to be greater than reported here.
This analysis assumes no impact of EDAET on inci-
dence, although a comparison of the baseline and post-
intervention surveys in the control villages suggests that
EDAET might itself be reducing transmission. This as-
sumption does not impact on the incremental cost/gain
of either of the strategies compared with each other, but
it could potentially underestimate the relative advantage
of EDAET as compared with a baseline of doing nothing,
while overestimating that of ITN.
Discussion
The results of this study suggest that ITNs provided some
protection for children against malaria in most villages in
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and the overall result was that there was no significant
benefit evident from their deployment. Malaria episodes
were less common overall in villages with ITN than in
the control group, because differences in favour of
ITN were greater than differences in favour of no nets
(Figures 3 and 4), but when these data were aggregated
per cluster, systematic use of ITN was not found to reduce
either falciparum or vivax malaria significantly. Importantly
they also did not attenuate the adverse consequences of
malaria on anaemia or growth. This study focussed on
children, as they are the most vulnerable age group for
malaria in this area. This provided the highest estimate
of potential protective efficacy and thus benefit from
ITN, as children go to bed earlier and they sleep longer
than adults (particularly relevant in this area with early
evening outdoor biting vectors [22]), and they are less
likely to travel far from the house. As all villagers in the
ITN clusters were provided with a net, any positive out-
come could have been further enhanced through a mass
insecticidal effect on the malaria vectors. In these vil-
lages malaria affected children more than adults but
malaria in the South East Asian region is often a disease
particularly affecting young mobile adults who work in
the forest and do not tend to use nets, so any benefits
demonstrated here are likely to be greater than in the
total population at risk in the region [23-25]. Adherence
with instructions for correct use of ITN was generally
good, but as the benefits were small, incorrect use did
not lead to more malaria. Even though the ITN and
control clusters were selected randomly, the malaria
prevalence before the study was higher in the study
villages than in the control villages. This might indicate
a higher endemicity, which could have influenced the
incidence and final prevalence results of the ITN clus-
ters, but transmission intensity varies greatly per year
and the differences were small and unlikely to make a
material difference to the results. This study was tightly
controlled, with a high coverage and user rate compared
to the normal context of use. Despite this no significant
overall benefit from ITN deployment in terms of malaria
protection could be demonstrated. The proportion of
children with anaemia decreased both in villages provided
with ITNs and in the control villages over the duration of
the study. This is probably largely because diagnosis and
effective treatment of malaria were provided in all villages,
and because children with anaemia were treated promptly,
which emphasizes the benefit provided by prompt and
effective anti-malarial treatment in such areas of low
unstable transmission [5,26].
The most likely explanation for this rather disappoint-
ing result from ITN deployment in this malaria endemic
area of Western Myanmar is the early evening biting
pattern and strong preference for outdoor biting of mostmalaria vectors in this area [22], as in many other areas
of South-East Asia [10-15,27-30]. Focussing on the hu-
man bite catches between July 1998 and January 2000
(n = 2,895), the overall peak biting time was between
6 pm and 7 pm, and over half of the anophelines (51%)
were caught before 8 pm. This would differentiate any
benefits of ITNs between children, who are often in or
near an ITN at this time, and adults who often are not. As
the behaviour of malaria vectors differs so much, particu-
larly in Asia, entomological information is essential before
ITNs are deployed. These somewhat negative results con-
trast with the widespread positive perception of the uni-
form value of ITNs in malaria control. A systematic review
of ITN evaluations [9], which included 22 studies from
Africa, Asia and South America, concluded that ITNs
reduce childhood morbidity and mortality and that ITNs
should be employed in all malarious areas. Over the past
decade ITNs have been taken up enthusiastically as a key
component of many malaria control programmes, but
caution is needed in interpreting the findings from bed
net studies with different designs and analytical methods.
According to Lengeler, of 29 identified studies conducted
in Asia, only four studies [10,12,31,32] used correct statis-
tical procedures for their trials and were included in the
meta-analysis. Another study [11] did use correct statistical
procedures, but was not included because it studied only
pregnant women. Of these five “statistically correct” studies,
three showed reduced morbidity [10,12,31] while the other
two did not [11,32]. In other studies, non-comparable
control groups were used or ITN were allocated at a
village-level, whereas end-points were calculated for
individuals. There is no doubt concerning the consistent
and large benefits provided by ITNs in Africa which fully
justifies current deployment initiatives. In contrast, the
epidemiology of malaria in Asia is extremely heteroge-
neous. Transmission is highly seasonal and unstable and
intensities vary greatly over short distances, and also show
great variation from year to year. It is not surprising that
ITNs are relatively ineffective in areas of unstable malaria
where the principal malaria vectors bite outdoors early in
the evening, before people go in or near their ITN. This
and previous studies argue against generalising from ITN
studies in Africa to the rest of the malaria affected world.
Where the main malaria vectors bite mainly indoors after
adults and children have gone to sleep, ITNs should be
very effective, but in many places, this is not the case. This
is not to say that ITNs provide no benefit in these places–
they do protect against malaria [33], albeit sometimes to a
small extent, and if cost were no obstacle then everyone in
malaria endemic areas should certainly be provided with
an ITN. But funds for malaria control are usually limited
and ITN deployment is often included uncritically in
many malaria control efforts in Asia in preference to other
control measures.
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morbidity and mortality, but in a large proportion of
patients in south and Southeast Asia, the diagnosis of
malaria is still made clinically and, therefore, incor-
rectly. A lack of resources means that most patients
with malaria in Myanmar and in adjacent countries
under similar constraints still receive inadequate treat-
ment. Many patients take a few tablets of artesunate
until they feel better. Sometimes chloroquine is still
used which is inexpensive but ineffective. Artesunate-
based combination treatment is a proven highly effective
treatment, which significantly reduces malaria transmission
in low-transmission areas. Without accounting for these
transmission blocking properties, the present economic
model indicates that effective diagnostic and treatment
(EDAET) services are less costly and substantially more
effective than ITN, when comparing each of these to a
baseline of no intervention, which is still the reality in
some areas in Myanmar. Once EDAET is implemented
effectively, ITNs can still provide additional benefit.
During the extended interval since this study was car-
ried out there has been a consistent and substantial de-
cline in malaria incidence across the region, including
many areas in Myanmar even when allowing for im-
proved reporting rates [34]. While the Rakhine state still
accounts for approximately half the burden in Myanmar,
the incidence rates reported in this study are likely to be
higher than those that would be documented today in
this region. This could further strengthen the argument
in favour of EDAET. Lower incidence of malaria will
imply that protective measures which require the same
costs applied to the entire population will be relatively
less cost-effective than those that target infected individ-
uals such as diagnosis and treatment.
ITNs are very popular with international donor agencies.
Millions of dollars are spent on ITN programmes in this
populous malaria endemic region. ITNs are both provided
free by donor organizations or promoted through social
marketing, encouraging the population to purchase their
own ITN. In this malaria endemic region of Myanmar, the
economic modelling based on the study data and contem-
porary prices suggests that early-diagnosis and effective
treatment is substantially more cost-effective than deploy-
ment of LLINs as a malaria control measure. This argues for
careful evaluation in each region before large-scale deploy-
ment. The findings here provide some evidence of a protect-
ive efficacy of ITNs in areas of higher endemicity within this
region, suggesting that they can be a cost-effective interven-
tion in the context of improving child health. If, however,
donor funding is targeting specifically the control of malaria
and ultimately its elimination from the region it seems likely
that improving preventive, diagnostic and curative inter-
ventions for all ages and particularly in adult, often migrant
males, could offer better returns on investment.Conclusion
Malaria infections, palpable splenomegaly, haemoglobin
concentrations, and weight for height, did not differ
significantly during the study period between villages
with and without ITNs. The limited efficacy of ITNs
may be explained by the biting behaviour (peak biting
time between 1800 and 1900 hours, mainly outdoors) of
the most common Anopheles mosquito vectors [22]. Given
the lack of significant efficacy and relatively high costs of
ITNs, the first priority in implementation of malaria control
interventions in this area should be the provision of effect-
ive diagnosis and treatment. Where EDAET services are
already in place and sufficient budgets are available then
the use of ITN can be cost-effective.
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